Lecanemab, Clinical Trials, and the Importance of Clinical Meaningfulness
Dementia Matters14 Juni 2023

Lecanemab, Clinical Trials, and the Importance of Clinical Meaningfulness

On June 9, 2023, the Food and Drug Administration’s (FDA) advisory committee unanimously voted to approve lecanemab, moving the treatment one step closer to full FDA approval. In the lead up to the FDA’s official announcement expected in early July, Dr. Paul Aisen joins the podcast to discuss Alzheimer’s disease clinical trials. Aisen, the founding director of the Alzheimer’s Therapeutic Research Institute (ATRI) and a leading figure in Alzheimer’s disease research for over three decades, talks about the Phase 3 clinical trials for lecanemab and gantenerumab and shares highlights from the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference.

Guest: Paul Aisen, MD, professor of neurology, Keck School of Medicine, University of Southern California, Director, Alzheimer’s Therapeutic Research Institute

Show Notes

Find out more about Dr. Aisen on Keck School of Medicine’s website.

Follow the Alzheimer’s Therapeutic Research Institute on Facebook andTwitter.

Listen to the episode with Dr. Roderick Corriveau, “Mixed Dementia, Explained” on our website, Spotify, Apple Podcasts, Podbean, and all major podcast platforms.

Connect with us

Find transcripts and more at our website.

Email Dementia Matters: dementiamatters@medicine.wisc.edu

Follow us on Facebook and Twitter.

Subscribe to the Wisconsin Alzheimer’s Disease Research Center’s e-newsletter.

Avsnitt(234)

The Importance of Early Dementia Detection and Diagnosis

The Importance of Early Dementia Detection and Diagnosis

Many adults are diagnosed with dementia at later stages or not diagnosed at all, despite how critical early detection is. Why is this the case? Dr. Chin discusses a recent article that highlights some...

21 Apr 9min

Unpacking the U.S. POINTER Study

Unpacking the U.S. POINTER Study

The U.S. POINTER study is one of the first large-scale, randomized controlled clinical trials to focus on how lifestyle interventions impact dementia risk and cognitive decline. On a special bonus epi...

15 Apr 43min

Navigating Difficult Conversations about Driving and Dementia

Navigating Difficult Conversations about Driving and Dementia

Driving can be a sensitive topic as a person gets older, and especially so when someone begins experiencing cognitive decline or is diagnosed with dementia. How can family members and care partners di...

7 Apr 32min

The Role of Social Work in Dementia Care

The Role of Social Work in Dementia Care

People with dementia and their families see many different doctors and health care providers following a diagnosis. Some may be surprised to know that social workers play a role in dementia care as we...

24 Mars 35min

Training for Clinical Trials with the IMPACT-AD Program

Training for Clinical Trials with the IMPACT-AD Program

Are you a researcher interested in getting involved in Alzheimer’s disease and related dementias (ADRD) clinical trials? The Institute on Methods and Protocols for Advancement of Clinical Trials in AD...

10 Mars 36min

How Ultra‑Processed Foods Impact Your Overall Health

How Ultra‑Processed Foods Impact Your Overall Health

Ultra-processed foods are a hot topic in the fields of health and nutrition, but what exactly are they and how do they impact our overall well-being? Dr. Beth Olson joins the podcast to explain what t...

24 Feb 27min

On the Pulse: How Resting Heart Rate Improves a Dementia Risk Score’s Accuracy

On the Pulse: How Resting Heart Rate Improves a Dementia Risk Score’s Accuracy

What if your heartbeat could help determine your dementia risk? The CAIDE dementia risk score has long helped clinicians estimate midlife risk for dementia using cardiovascular health factors, but its...

10 Feb 29min

Could Managing Four Common Health Conditions Slow Cognitive Decline from Alzheimer’s?

Could Managing Four Common Health Conditions Slow Cognitive Decline from Alzheimer’s?

Alzheimer’s disease isn’t always the only health condition a person faces, so how does treating other diseases impact the progression of Alzheimer’s? Researchers at the University of Arizona focused o...

27 Jan 27min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
det-morka-psyket
rss-spraket
rss-vetenskapsradion
rss-ufo-bortom-rimligt-tvivel-2
medicinvetarna
hacka-livet
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
sexet
dumforklarat
rss-tidslinjen-podcast
bildningspodden
halsorevolutionen
4health-med-anna-sparre
naturmorgon